Single-Neuron Brain Interfaces and Stroke Recovery — Insights from Stanford's Brain Interfacing Lab

Overview

Short Wave host Rachel Carlson sits down with Stanford neuroscientist Paul Nijukian to explore brain-machine interfaces, focusing on recording from single neurons in the brain to understand movement control and stroke recovery. The conversation covers how tiny, surgically implanted electrodes allow researchers to measure neuron-to-neuron communication, what happens when small brain injuries occur, and how these insights might inform the design of future medical devices for brain diseases.

• Single-neuron recording reveals how the brain compensates after injury and what signatures of recovery look like.
• Off-label device pathways could speed clinical impact by repurposing approved brain devices for stroke and other conditions.
• Linking neural signals to behavior may guide therapies that nudge the brain back toward normal function.
• Ethical and safety considerations are evolving as devices move toward measuring individual neurons.

Overview

The podcast centers on Paul Nijukian, a neuroscientist at Stanford's Brain Interfacing Lab, who transitioned from early work with brain-machine interfaces for tetraplegia to studying stroke recovery. Nijukian explains that stroke disrupts blood flow and causes tissue to die, with consequences that vary widely between individuals. The discussion introduces the laboratory's focus on recording from single neurons in primate brains, a departure from the more common practice of observing neural populations. The goal is to connect tiny neural events to observable movement, laying groundwork for therapies that could one day restore function after brain injury.

The host, Rachel Carlson, and Nijukian reveal how their lab uses a unique approach—monitoring individual neurons rather than aggregated groups—to gain a finer picture of brain activity during movement tasks. This granular view is intended to illuminate how the brain adapts after injury and what patterns persist as the brain recovers.

Methods: Recording Single Neurons in Monkey Brains

The core technique involves surgically implanted electrodes—tiny wires—that measure the voltage changes produced by individual neurons. Nijukian describes the method as dipping into the brain's “stands” rather than observing a crowded stadium from afar. The recording of single-neuron activity provides higher resolution data than typical multi-neuron population analyses, enabling researchers to detect subtle shifts in neural signaling that drive movement. In the lab, monkeys perform reaching tasks to chase a green dot on a screen, receiving juice rewards as they succeed. These tasks are designed to reveal how precise motor planning and execution are reflected in the activity of individual neurons.

In this section the host and scientist discuss real-world lab practices, and the imaging of neural communication through implanted microelectrodes, which capture rapid, millisecond-scale neural events that govern movement control. The vivid analogy is used to help listeners understand the complexity and richness of signals emanating from single neurons and how these signals translate into behavior.

“we do it with these tiny little wires that are implanted surgically into the brain. These little wires, called electrodes, measure the individual voltage changes that one neuron signals to another” - Paul Nijukian

Stroke Injury and Immediate Neural Dynamics

A key part of Nijukian’s work is investigating how the brain responds to very small, localized injuries at the electrode sites to model stroke. The team induces tiny injuries in a way that is invisible behaviorally to the monkeys, allowing researchers to observe immediate changes in the activity of the remaining neurons. The changes in neural activity last for a few days to roughly a week, after which the neural patterns and behavior tend to recover toward their pre-injury states. Nijukian emphasizes that the extent of neural loss they simulate is small enough that recovery is plausible, offering a model for understanding human recovery after stroke. The central aim is to determine whether the mechanisms driving this recovery are conserved across species, which would support extrapolation to human patients.

From this work, scientists infer signatures of brain activity that persist after recovery and shift during injury, a finding that could enable clinicians to track recovery trajectories and tailor therapies accordingly. This section also touches on the broader implication that, even when tissue is damaged, remaining neural networks can reorganize in ways that restore function, at least to a meaningful degree, in controlled settings.

“the degree of neural loss that we are generating, the brain can recover from” - Paul Nijukian

From Neurons to Human Therapy: Signatures of Recovery

Looking toward human applications, Nijukian describes signatures of neural activity that appear to be conserved after recovery and altered during injury. If similar patterns exist in people, these signatures could be used to monitor recovery from brain injuries such as stroke, track how much of the brain is damaged, and quantify how far a patient is from normal function. The researchers posit that with enough single-neuron data, clinicians could more accurately gauge brain state and recovery progress, which would be invaluable for guiding rehabilitation strategies and evaluating new therapies. The broader implication is that measuring brain activity at the level of individual neurons could provide a bedrock for developing therapies that bring the brain back toward its normal operating range, moving beyond proxies currently used in many clinical tools.

“the promise for studying single neurons, if we can measure enough of them simultaneously, is to carefully estimate and understand what the brain itself is doing in the setting of these diseases and injuries” - Paul Nijukian

Clinical Translation: Off-Label Use and New Device Categories

One practical challenge discussed is how medical devices move from research to clinic. Nijukian explains that in medical device development, once one device is approved and market access is obtained, researchers gain access to “off-label use” of the technology for other indications. This off-label path can lower barriers and costs for exploring additional brain diseases beyond the device’s original target. A major point is that, to date, there is not a single device approved for routinely recording individual neurons in clinical settings; researchers have often relied on proxies and downstream effects rather than direct brain recordings. The conversation uses a diabetes analogy: we currently infer brain function by indirect measures rather than directly reading neural signals, a gap that, if addressed, could transform disease treatment. Nijukian suggests that the future may involve a new category of brain devices that directly measure single-neuron activity to diagnose and treat brain diseases more precisely. The host and guest acknowledge safety, surgical risks, and regulatory hurdles, but the potential safety and risk landscape for neuromodulation and neural recording devices has improved over the past two decades, making such a shift increasingly plausible.

“And once that's in place, researchers have access to what's called off label use” - Paul Nijukian

These discussions underscore the broader ambition of Future Factual’s interview to connect high-resolution neuroscience with practical clinical pathways, bridging basic discovery and patient care. The episode closes with reflections on how discoveries from single-neuron studies could inform off-label device development, track recovery, and ultimately advance a new paradigm in treating brain diseases beyond stroke, exemplifying the podcast’s aim to illuminate the science behind advances in neural interfaces.

“the degree of neural loss that we are generating, the brain can recover from” - Paul Nijukian